Most people on Mounjaro (tirzepatide) notice reduced appetite within the first week or two, with measurable weight loss usually building gradually from the first month onwards as the dose is increased. In the SURMOUNT-1 trial, participants on the 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
There is no fixed weekly weight-loss figure, because Mounjaro works by steadily stepping up the dose over several months. Below is a realistic, week-by-week guide to what tends to happen and why — but your own pace is decided with your prescriber, not by a calendar.
How does Mounjaro actually work week by week?
Mounjaro is a weekly self-injection that activates two gut-hormone receptors — GLP-1 and GIP — at the same time. This reduces appetite, slows how quickly the stomach empties, and helps you feel fuller sooner and for longer, so you naturally eat less without constant hunger.
Because the medicine is titrated (increased in steps), the early weeks are about letting your body adjust rather than chasing the scales. The appetite effect often appears before large weight changes, which is why many people describe "feeling different" before they "look different". You can read the full mechanism on the Mounjaro page.
What is the Mounjaro dose schedule in the UK?
In the UK, Mounjaro starts at a low 2.5mg starter dose and is increased gradually under prescriber review, up to a maximum licensed dose of 15mg once weekly. The starter dose is designed to limit side effects, not to drive maximum weight loss, so early weeks are an adjustment phase.
| Phase | Dose (weekly) | Main purpose |
|---|---|---|
| Starter (around weeks 1–4) | 2.5mg | Let your body adjust; reduce early side effects |
| Step up | 5mg | First "active" treatment dose for many people |
| Step up | 7.5mg | Continued appetite control |
| Step up | 10mg | Further dose escalation if needed |
| Step up | 12.5mg | Approaching maximum |
| Maximum licensed | 15mg | Highest licensed dose if clinically appropriate |
Each step is usually held for at least four weeks before moving up, and only if you are tolerating the current dose. Not everyone needs or reaches 15mg — some people lose weight well on a lower maintenance dose.
When does weight loss actually start on Mounjaro?
Appetite reduction often begins within the first one to two weeks on the 2.5mg starter dose, while visible weight loss usually becomes clearer across weeks four to twelve as the dose increases to 5mg and beyond. The earliest change on the scales can partly be water and reduced food volume rather than fat loss alone.
Weight loss tends to be gradual and non-linear — some weeks drop more than others, and plateaus are normal. A steady downward trend over months matters far more than any single week, and a slow, sustainable rate is generally considered safer and easier to maintain.
What might the first few months look like?
The timeline below is a general illustration of patterns many UK patients describe — it is not a prediction or a promise, because weight loss on Mounjaro varies widely between individuals.
- Weeks 1–4 (2.5mg starter): reduced hunger and smaller portions; some early weight change; side effects such as nausea are most common now as your body adjusts.
- Weeks 5–8 (often 5mg): appetite suppression usually more consistent; weight loss typically becomes more noticeable.
- Weeks 9–16 (stepping up further): continued gradual loss; many people settle into a routine; side effects often ease as the body adapts.
- Months 4–12+: dose adjusted toward the level that works for you; weight loss continues more slowly; plateaus are expected and do not mean failure.
The headline 22.5% average from SURMOUNT-1 was measured over a full 72 weeks on the 15mg dose, alongside lifestyle support. Individual results vary; not everyone reaches this, and results over shorter periods are naturally smaller.
Why are results different for everyone?
Weekly and overall results differ because weight loss depends on your starting weight, your diet and activity, the dose you reach, how your body responds, and whether you can stay on treatment consistently. Mounjaro is a tool that reduces appetite — the food and movement choices you make alongside it strongly influence the outcome.
This is why Mounjaro is licensed for use alongside a reduced-calorie diet and increased physical activity, not on its own. It is also why comparing your week-three progress to someone else's is rarely helpful.
What can affect your weekly progress?
- Dose stage: early starter weeks are about tolerance, so loss is usually slower than later on.
- Protein and fibre intake: help preserve muscle and keep you full on fewer calories.
- Hydration and sleep: poor sleep and dehydration can stall progress and worsen fatigue.
- Activity, including resistance work: supports muscle retention during weight loss.
- Consistency: missed doses or stopping early interrupts the appetite effect.
What side effects should you expect, and when?
The most common Mounjaro side effects (affecting more than 1 in 10 people) are nausea, diarrhoea, constipation, vomiting, decreased appetite and fatigue. These tend to be most noticeable in the first weeks after starting and after each dose increase, and often settle as your body adjusts.
Rare but serious risks include severe allergic reaction, acute pancreatitis, severe hypoglycaemia, severe gastrointestinal disease and worsening diabetic retinopathy. Seek urgent medical advice for severe or persistent symptoms, and report any suspected side effect through the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
Who is eligible for Mounjaro in the UK?
Mounjaro is a prescription-only medicine available in the UK only after a clinical consultation with a GPhC-registered prescriber. Eligibility generally applies to adults aged 18 and over with a BMI of 30 or more, or a BMI of 27 or more with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea.
It is not suitable if you are pregnant, planning pregnancy or breastfeeding; have type 1 diabetes, a personal or family history of medullary thyroid carcinoma or MEN2, a history of pancreatitis, severe gastrointestinal disease, an active eating disorder, severe liver or kidney impairment, or a known allergy to the active ingredient. You can check your suitability with a free online consultation.
How does Mounjaro compare to other options?
Mounjaro is one of several licensed weight-management medicines. Others include the Wegovy injection (semaglutide), the Wegovy Tablet (oral semaglutide), and Foundayo (orforglipron), a small-molecule GLP-1 taken as a once-daily tablet at any time of day. The right choice depends on your health, preferences and a prescriber's clinical judgement.
You can compare the full range on the treatments and weight-loss injections pages. A prescription is only issued if a treatment is clinically appropriate for you — it is never guaranteed.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
